PEOPLE - Changes at Medtronic (US):
This article was originally published in Clinica
Executive Summary
Ronald Lund has returned to his former post at Medtronic (Minneapolis, Minnesota) as general counsel and corporate secretary, following the resignation of David Scott. His reappointment is not connected with the US government's November 2003 subpoena served to Medtronic that seeks document related to allegations of kickbacks to GPs, the company said in statements to the press this week.
You may also be interested in...
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.